D2PM Stats & Data
Diphenylprolinol
NPS DataHub
MW289.8
FormulaC17H20ClNO
CAS16226-54-3
IUPACdiphenyl-pyrrolidin-2-ylmethanol hydrochloride
SMILES
[Cl-].OC(C1CCCN1)(c1ccccc1)c1ccccc1.[H+]InChIKey
XYSYRXOJSOXZPT-UHFFFAOYSA-N
Psychoactive Class
Stimulant
Receptor Profile
Receptor Actions
Inhibitors
Dopamine-norepinephrine reuptake inhibitor (NDRI)
Effect Profile
Curated
Stimulant
3.8
Strong anxiety/jitters with moderate stimulation and euphoria
Stimulation / Energy×3
6
Euphoria / Mood Lift×2
6
Focus / Productivity×2
0
Anxiety / Jitters×1
10
Based on reports from:
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1d
Half tolerance
10d
Baseline
~18d
Legal Status
| Country | Status | Notes |
|---|---|---|
| United States | Uncontrolled |
References
Data Sources
Cited References
- ACMD advice on diphenyl-2-pyrrolidinyl-methanol (D2PM)
- Corkery JM et al. 2-DPMP and D2PM: A preliminary review. Prog Neuropsychopharmacol Biol Psychiatry 2012
- Drugs-Forum: D2PM experiences thread
- TripSit: D2PM Factsheet
- Wood DM et al. Cardiovascular toxicity from D2PM use. J Med Toxicol 2008
- Wood DM et al. Use and acute toxicity of D2PM and 2-DPMP. Clin Toxicol 2012
- Meltzer SC et al. Receptor binding profile of diphenylprolinol. J Psychopharmacol 2010
- Cardiovascular toxicity from recreational D2PM use. J Med Toxicol 2008
- Corkery JM et al. Preliminary review of D2PM and 2-DPMP. Prog Neuro-Psychopharmacol 2012
- Wood DM & Dargan PI. Acute toxicity of D2PM and 2-DPMP. Clin Toxicol 2012
- ScienceDirect: Topics – user dose reports (20-50 mg oral, 5-10 h duration)
- Bluelight: D2PM experiences thread